![Que Huong Dong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Que Huong Dong
Chief Executive Officer at
ELECTRA THERAPEUTICS, INC.
Net worth: 5 $ as of 2026-08-30
Profile
Dr. Que Huong Dong is a President, Chief Executive Officer & Director at Electra Therapeutics, Inc. She is on the Board of Directors at Electra Therapeutics, Inc. and Neuron23, Inc. Dr. Dong was previously employed as a Chief Operating Officer by Star Therapeutics, Inc., a Chief Operating Officer by Vega Therapeutics, Inc., a Head-New Product Planning by Sanofi, a Director-HCV Marketing by Gilead Sciences, Inc., and a Vice President-Commercial Development by True North Therapeutics, Inc. She received her MBA from the University of New Mexico School of Medicine and a doctorate degree from the University of New Mexico School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-20 | 455,484 ( 1.16% ) | 5 $ | 2026-08-30 |
Que Huong Dong active positions
| Companies | Position | Start |
|---|---|---|
| ELECTRA THERAPEUTICS, INC. | Chief Executive Officer | 2023-09-30 |
Neuron23, Inc.
 Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Director/Board Member | 2022-06-13 |
Former positions of Que Huong Dong
| Companies | Position | End |
|---|---|---|
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Chief Operating Officer | 2023-09-30 |
Vega Therapeutics, Inc.
 Vega Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engagers in R&D and manufactures antibodies that targets proteins | Chief Operating Officer | 2023-09-30 |
| SANOFI | Corporate Officer/Principal | 2019-02-28 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Corporate Officer/Principal | - |
Training of Que Huong Dong
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of New Mexico School of Medicine
 University of New Mexico School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vega Therapeutics, Inc.
Vega Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engagers in R&D and manufactures antibodies that targets proteins | Health Technology |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Neuron23, Inc.
Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological and cancer diseases | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
- Stock Market
- Insiders
- Que Huong Dong
